A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

MOTE Therapeutics (referred as MOTE), a seed-stage biotech developing targeted RNA delivery solutions, announced the appointment of MaryJane Rafii, PhD, MBA, as Chief Investment and Business Officer.

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

A strategy that analyzes the structural properties of RNA could help identify regions that are promising targets for antiviral drugs.

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

A historic wall at the Brisbane Showgrounds adorned with murals from street artists has been demolished as part of the ...

This article makes a valuable contribution to the field by uncovering a molecular mechanism for miRNA intracellular retention, mediated by the interaction of PCBP2, SYNCRIP, and specific miRNA motifs.